Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2010

Open Access 01-12-2010 | Research article

The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program

Authors: Alireza Khosravi, Gilda Kiani Mehr, Roya Kelishadi, Shahin Shirani, Mojgan Gharipour, Aliakbar Tavassoli, Fatemeh Noori, Nizal Sarrafzadegan

Published in: BMC Cardiovascular Disorders | Issue 1/2010

Login to get access

Abstract

Objectives

We aimed to evaluate the changes over time in the prevalence, awareness, treatment, and control rate of hypertension in intervention and reference areas of a comprehensive community trial with reference area.

Methods

Data from independent sample surveys before and after implementation of the program (2001 vs.2007) were used to compare differences in the intervention and references areas over time. Hypertension was defined as blood pressure ≥140/90 mmHg in non-diabetic patients and ≥130/80 mmHg in diabetic individuals and or taking antihypertensive medications. Interventional activities included educational strategies at population level as well as for hypertensive patients, their families and health professionals.

Results

The study population of the baseline survey included 6175 (48.7% males) in the interventional area and 6339 (51.3% male) in the reference area. The corresponding figures in the post-intervention phase was 4717 (49.3% male) in the interventional area and 4853 (50.7% male) individuals in the reference area. The prevalence of hypertension had a non-significant decrease from 20.5%to 19.6%, in the interventional area whereas in the reference area, it increased from 17.4% to 19.6% (P = 0.003). If we consider Bp ≥ 140/90 in diabetic and non-diabetic patients as hypertension definition, the prevalence of hypertension in the interventional areas had a non-significant decrease from 18.9% in 2001 to 17.8% in 2007, whereas in the reference area, it had a significant rise from 15.7% to 17.9% (P = 0.002) respectively. Awareness, treatment and control rates of hypertension had better improvement in urban and rural part of the interventional area compared to reference area. The awareness, treatment, and control rates of hypertension increased significantly in the age groups of more than 40 years, as well as in all groups of body mass index in interventional areas without significant change in the reference area. Mean systolic blood pressure of study population in the interventional area decreased from 116.13 ±19.37 to 112.92 ± 18.27 mmHg (P < 0.001) without significant change in reference area.

Conclusions

This comprehensive and integrated program of interventions was effective in tackling with the prevalence of hypertension, and may improve the awareness, treatment and control rates of this disorder in a developing country setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365 (9455): 217-23.CrossRefPubMed Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365 (9455): 217-23.CrossRefPubMed
2.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360 (9349): 1903-13. 10.1016/S0140-6736(02)11911-8.CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360 (9349): 1903-13. 10.1016/S0140-6736(02)11911-8.CrossRefPubMed
3.
go back to reference Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ: Selected major risk factors and global and regional burden of disease. Lancet. 2002, 360 (9343): 1347-60. 10.1016/S0140-6736(02)11403-6.CrossRefPubMed Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ: Selected major risk factors and global and regional burden of disease. Lancet. 2002, 360 (9343): 1347-60. 10.1016/S0140-6736(02)11403-6.CrossRefPubMed
5.
go back to reference Cheung BM, Ong KL, Man YB, Lam KS, Lau CP: Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich). 2006, 8 (2): 93-8. 10.1111/j.1524-6175.2006.04895.x.CrossRef Cheung BM, Ong KL, Man YB, Lam KS, Lau CP: Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich). 2006, 8 (2): 93-8. 10.1111/j.1524-6175.2006.04895.x.CrossRef
6.
go back to reference Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289 (18): 2363-9. 10.1001/jama.289.18.2363.CrossRefPubMed Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003, 289 (18): 2363-9. 10.1001/jama.289.18.2363.CrossRefPubMed
7.
go back to reference Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al: Prevalence, awareness, treatment and control of hypertension in China. Hypertension. 2002, 40 (6): 920-7. 10.1161/01.HYP.0000040263.94619.D5.CrossRefPubMed Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al: Prevalence, awareness, treatment and control of hypertension in China. Hypertension. 2002, 40 (6): 920-7. 10.1161/01.HYP.0000040263.94619.D5.CrossRefPubMed
8.
go back to reference Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, et al: Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006, 24 (8): 1515-21. 10.1097/01.hjh.0000239286.02389.0f.CrossRefPubMed Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, et al: Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006, 24 (8): 1515-21. 10.1097/01.hjh.0000239286.02389.0f.CrossRefPubMed
9.
go back to reference Khosravi A, Pourmoghaddas M, Kelishadi R, Sabet B, Ansari R, Shirani S, et al: Trend in hypertension level, prevalance of hypertension and its care in Isfahan. MJIRC. 2005, 8 (2): 62-8. Khosravi A, Pourmoghaddas M, Kelishadi R, Sabet B, Ansari R, Shirani S, et al: Trend in hypertension level, prevalance of hypertension and its care in Isfahan. MJIRC. 2005, 8 (2): 62-8.
10.
go back to reference Sarraf-Zadegan N, Sadri G, Malek AH, Baghaei M, Mohammadi FN, Shahrokhi S, et al: Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol. 2003, 58 (4): 309-20. 10.2143/AC.58.4.2005288.CrossRefPubMed Sarraf-Zadegan N, Sadri G, Malek AH, Baghaei M, Mohammadi FN, Shahrokhi S, et al: Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol. 2003, 58 (4): 309-20. 10.2143/AC.58.4.2005288.CrossRefPubMed
11.
go back to reference Sarrafzadegan N, Baghaei A, Sadri Gh, Kelishadi R, Malekafzali H, Boshtam M, et al: Isfahan healthy heart program: Evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prevention and Control. 2006, 2: 73-84. 10.1016/j.precon.2006.10.003.CrossRef Sarrafzadegan N, Baghaei A, Sadri Gh, Kelishadi R, Malekafzali H, Boshtam M, et al: Isfahan healthy heart program: Evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prevention and Control. 2006, 2: 73-84. 10.1016/j.precon.2006.10.003.CrossRef
12.
13.
go back to reference Shirani Sh, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri Gh, Amani S, Heidari S, Ramezani MA: Awareness, treatment and control of hypertension, duslipidemia and diabetes mellitus in an Iranian population. East Med Health J. 2009, 15 (6): 1474-1483. Shirani Sh, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri Gh, Amani S, Heidari S, Ramezani MA: Awareness, treatment and control of hypertension, duslipidemia and diabetes mellitus in an Iranian population. East Med Health J. 2009, 15 (6): 1474-1483.
14.
go back to reference Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003, 290 (2): 199-206. 10.1001/jama.290.2.199.CrossRefPubMed Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003, 290 (2): 199-206. 10.1001/jama.290.2.199.CrossRefPubMed
15.
go back to reference Kannel WB: Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res. 1995, 18 (3): 181-96. 10.1291/hypres.18.181.CrossRefPubMed Kannel WB: Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res. 1995, 18 (3): 181-96. 10.1291/hypres.18.181.CrossRefPubMed
16.
go back to reference Nissinen A, Tuomilehto J, Elo J, Alasoini A, Varvikko P, Puska P: North Karelia (Finland) hypertension detection project. Five-year follow-up of hypertensive cohort. Hypertension. 1983, 5 (4): 564-72.CrossRefPubMed Nissinen A, Tuomilehto J, Elo J, Alasoini A, Varvikko P, Puska P: North Karelia (Finland) hypertension detection project. Five-year follow-up of hypertensive cohort. Hypertension. 1983, 5 (4): 564-72.CrossRefPubMed
17.
go back to reference Cheung BM, Ong KL, Man YB, Lam KS, Lau CP: Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich). 2006, 8 (2): 93-8. 10.1111/j.1524-6175.2006.04895.x.CrossRef Cheung BM, Ong KL, Man YB, Lam KS, Lau CP: Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich). 2006, 8 (2): 93-8. 10.1111/j.1524-6175.2006.04895.x.CrossRef
18.
go back to reference Maldonado J: Blood pressure screening, management and control in England: results from the Health Survey for England 1994. Rev Port Cardiol. 1999, 18 (10): 959-60.PubMed Maldonado J: Blood pressure screening, management and control in England: results from the Health Survey for England 1994. Rev Port Cardiol. 1999, 18 (10): 959-60.PubMed
19.
go back to reference Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P: Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997, 10 (10 Pt 1): 1097-102. 10.1016/S0895-7061(97)00224-0.CrossRefPubMed Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P: Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997, 10 (10 Pt 1): 1097-102. 10.1016/S0895-7061(97)00224-0.CrossRefPubMed
20.
go back to reference Vargas CM, Ingram DD, Gillum RF: Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol. 2000, 152 (3): 272-8. 10.1093/aje/152.3.272.CrossRefPubMed Vargas CM, Ingram DD, Gillum RF: Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol. 2000, 152 (3): 272-8. 10.1093/aje/152.3.272.CrossRefPubMed
21.
go back to reference Hyman DJ, Pavlik VN: Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001, 345 (7): 479-86. 10.1056/NEJMoa010273.CrossRefPubMed Hyman DJ, Pavlik VN: Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001, 345 (7): 479-86. 10.1056/NEJMoa010273.CrossRefPubMed
22.
go back to reference Barker WH, Mullooly JP, Linton KL: Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension. 1998, 31 (1 Pt 2): 552-9.CrossRefPubMed Barker WH, Mullooly JP, Linton KL: Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension. 1998, 31 (1 Pt 2): 552-9.CrossRefPubMed
23.
go back to reference Tesfaye F, Nawi NG, Van MH, Byass P, Berhane Y, Bonita R, et al: Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hypertens. 2007, 21 (1): 28-37. 10.1038/sj.jhh.1002104.CrossRefPubMed Tesfaye F, Nawi NG, Van MH, Byass P, Berhane Y, Bonita R, et al: Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hypertens. 2007, 21 (1): 28-37. 10.1038/sj.jhh.1002104.CrossRefPubMed
24.
go back to reference Njelekela M, Negishi H, Nara Y, Tomohiro M, Kuga S, Noguchi T, et al: Cardiovascular risk factors in Tanzania: a revisit. Acta Trop. 2001, 79 (3): 231-9. 10.1016/S0001-706X(01)00134-6.CrossRefPubMed Njelekela M, Negishi H, Nara Y, Tomohiro M, Kuga S, Noguchi T, et al: Cardiovascular risk factors in Tanzania: a revisit. Acta Trop. 2001, 79 (3): 231-9. 10.1016/S0001-706X(01)00134-6.CrossRefPubMed
25.
go back to reference Kadiri S, Walker O, Salako BL, Akinkugbe O: Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens. 1999, 13 (1): 23-7. 10.1038/sj.jhh.1000722.CrossRefPubMed Kadiri S, Walker O, Salako BL, Akinkugbe O: Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens. 1999, 13 (1): 23-7. 10.1038/sj.jhh.1000722.CrossRefPubMed
Metadata
Title
The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: experiences from the Isfahan healthy heart program
Authors
Alireza Khosravi
Gilda Kiani Mehr
Roya Kelishadi
Shahin Shirani
Mojgan Gharipour
Aliakbar Tavassoli
Fatemeh Noori
Nizal Sarrafzadegan
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2010
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-10-61

Other articles of this Issue 1/2010

BMC Cardiovascular Disorders 1/2010 Go to the issue